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Intravascular lipoma of the left common 
femoral vein
Mohammed Al-Omran, MD, and Daryl S. Kucey, MD, MSc, MPH, FRCSC, Toronto, Ontario
Lipomatous tumors of the heart and major central veins are unusual pathologic findings. We report an intravascular
lipoma arising directly from the wall of the left common femoral vein (LCFV) in a patient who had progressive left leg
swelling and in whom a deep venous thrombosis in the LCFV was initially diagnosed. This is the first case report of
such a tumor in the literature. The computed tomography, magnetic resonance imaging, and intraoperative features are
presented. The procedure of tumor excision and venous reconstruction with a cadaveric allograft is described. (J Vasc
Surg 2001;33:1104-7.)
A lipoma is a benign circumscribed tumor composed
of well-differentiated adipocytes and is the most common
soft tissue mass. The tumor can originate at any site in the
body that contains adipose tissue, but typically it arises in
subcutaneous tissues of the upper half of the body and
proximal extremities.1
Primary venous tumors are unusual in any location,
and the walls of veins are only rarely the site of origin of a
neoplasm.2 Furthermore, lower-extremity primary venous
tumors are rare and usually malignant lesions. Benign
venous tumors are mainly represented by leimyomas.3,4
Although lipomas have been described as arising from the
heart, inferior vena cava, and superior vena cava, they have
not been reported to arise from a major vein of the lower
extremities.2,5-8 We present a case of left common femoral
vein (LCFV) intramural lipoma.
CASE REPORT
A 76-year-old man went to his family physician with a 14-
month history of progressively increasing swelling of his left leg.
His medical history was unremarkable. Duplex ultrasonography
was performed, and no evidence of deep vein thrombosis in the
left leg was found. The swelling progressively increased, and the
patient was eventually referred to the thromboembolism service
at Sunnybrook Health Science Centre. A 3 × 2-cm mass lesion in
the lumen of the LCFV was demonstrated by means of a second
duplex study performed 4 months later. This was diagnosed as a
small isolated thrombus in the deep venous system, and the
patient was treated with subcutaneous low molecular heparin for
5 days and oral warfarin for 3 months. The patient’s symptoms
did not decrease, and the swelling continued to increase, so the
patient eventually underwent a computed tomography (CT) scan
of the abdomen and pelvis, by means of which an intravascular
filling defect in the LCFV that had fatty tissue attenuation was
demonstrated (Fig 1). The diagnosis of an intravascular lipoma
was considered, and the patient was referred to the vascular
surgery service for further assessment and treatment. On exami-
nation, the left leg was twice the diameter of the right leg, and the
patient gave a history suggestive of venous claudication. A
venogram of the left leg was performed, by means of which an
abnormality in the posterior medial wall with a filling defect
extending over 2 to 3 cm of the vessel length just cephalad to the
saphenofemoral junction was demonstrated. A magnetic reso-
nance imaging (MRI) scan was performed as part of the exami-
nation, and the presence of an adipose tumor was confirmed (Fig
2). Because the patient had significant symptoms associated with
this mass, elective surgical excision of the tumor was planned.
Preoperatively, the oral warfarin was discontinued, and the patient
was given subcutaneous low molecular heparin.
At the time of surgery, an en-block resection of the LCFV
and tumor extension into the surrounding soft tissues was per-
formed (Fig 3). No thrombus was found in the resected segment
of the vein. An interposition tube graft of banked human cryo-
preserved iliac vein was obtained and used as a means of recon-
structing the LCFV.
Macroscopically, the tumor was arising from the posterior
aspect of the LCFV wall, with an area of extension outside the
wall. A protruding encapsulated piece of adipose tissue occluded
the venous lumen and measured 1.6 cm in length and 1.7 cm in
diameter. Histologically, the tumor was composed of uniform adi-
pose tissue, consistent with lipoma.
Postoperatively, the patient was given subcutaneous low mo-
lecular heparin for 3 days and oral warfarin. The postoperative
course was uneventful, and the swelling and symptoms subsided.
On the fifth postoperative day, the patient was still being given
oral warfarin and was discharged home. 
The patient was seen in the clinic after 6 months. There was
no swelling in the left leg, and a patent graft was shown by means
of a duplex study. The oral warfarin was discontinued.
At 9 months, the duplex study was repeated, and a patent
graft was shown.
DISCUSSION
This case of a primary intramural lipoma arising
directly from the wall of a major lower-extremity vein is
extremely rare. We are not aware of any reported cases in
the literature. A computerized literature search was con-
ducted in MEDLINE (1966 to April 2000) and EMBASE
(1980 to April 2000). The search used the keywords
intravascular neoplasm, veins, femoral vein, and lipoma.
Primary cardiac lipomas are well recognized, forming
8% of all cardiac tumors and 14% of all benign cardiac
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Fig 1. Computed tomography scan of the pelvis with intravenous contrast medium demonstrating an intravascular filling defect in left
common femoral vein that has fatty tissue attenuation (arrow).
Fig 2. Coronal section of magnetic resonance image shows extension of fatty tumor within left common femoral vein (arrows).
tumors.8 These tumors are usually asymptomatic, often
being recognized by means of routine chest radiography.9
Lipomas of the inferior vena cava have been described to
be a normal variant and are generally present as incidental
findings, with a frequency of approximately 0.5% in rou-
tine CT scans of the abdomen.5
Three cases of superior vena cava (SVC) primary intra-
mural lipoma have been reported in the literature.2,6,7 In
one report, a large tumor of fat density involving the right
brachiocephalic vein and the SVC was shown by means of
a CT scan. The patient was found to have clinical evidence
of a mild SVC obstruction, which was relieved by means of
surgical removal.2 In the second case, a lipoma of the SVC
was discovered by means of a CT scan performed after a
thoracic trauma, and it was surgically removed.6 The third
case of lipoma was not symptomatic, and the fatty nature
of the tumor was confirmed by means of an MRI; therefore
the lipoma was not surgically removed.7
CT scanning and MRI are presently the best radio-
logic imaging methods for diagnosing soft tissue tumors
and especially venous tumors, because they are means of
demonstrating the site of origin and the venous anatomy,
defining the relationship to the surrounding structure,
and identifying tissue characteristics that may lead to opti-
mization of the surgical intervention.10,11
Prosthetic grafts, autologous venous tube grafts, allo-
graft vein conduit, and spiral or panel saphenous vein grafts
have been used for venous reconstruction for different indi-
cations. All have the potential risk of thrombosis and occlu-
sion. In this situation, it was thought that the two reasonable
treatment options were the use of an autologous spiral or
panel vein graft or the use of a simple tube graft with a
cadaveric allograft. There is not a large experience in the lit-
erature of venous allografts in the treatment of venous occlu-
sive disease. Certainly, when this graft material has been used
as a conduit for femoral distal arterial reconstruction, the
results have not been encouraging, but when it is used as a
localized venous reconstruction of short length and large
diameter, in our local experience, it has been satisfactory.
The use of a cadaveric allograft allows simplification of the
intricacy of the procedure and minimization of the proce-
dural time. The long-term patency of human allografts in
venous reconstruction requires further study.
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Fig 3. Intraoperative photograph shows fatty tumor (white arrows) protruding from wall of left common femoral vein (LCFV). LFA,
Left femoral artery.
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